Eloïse Laouenan/LinkedIn
Aug 2, 2026, 12:13
Eloïse Laouenan: DEBRIEF Study Highlights Better Adherence with Early Debriefing
Eloïse Laouenan, PhD student in Life and Health Sciences at INSERM, midwife at CHU Brest, shared on LinkedIn:
”Very interesting presentation of Prof. Francis COUTURAUD about the impact of early debriefing and enhanced educative components of apixaban adherence and qol – DEBRIEF study at ISTH 2026.
Publication of complete results coming soon…”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 13:09Antonio Galante: Management of Portal Vein Thrombosis
-
Nov 14, 2026, 12:47Yasmin Mohtasham Kia: Anticoagulation Knowledge and Treatment Outcomes in Patients With Mechanical Heart Valves
-
Nov 14, 2026, 12:37Nathan Connell: Annualized Bleeding Rate and the Future of Hemophilia A Treatment
-
Nov 14, 2026, 12:3210 Posts Not to Miss This Week
-
Nov 14, 2026, 11:28Kalyan Roy: A New Era in Thalassemia Treatment – FDA Approves Mitapivat
-
Nov 14, 2026, 11:24Can Iron Deficiency Really be Seen in Someone’s Face? – ASH
-
Nov 14, 2026, 11:19Lindsay Davison: Putting Childhood Anemia in the Spotlight with IronUp and Danone
-
Nov 14, 2026, 10:00Benjamin Tur: Putting Iron Deficiency Anemia on the Global Agenda at the Paris Peace Forum’s Child Summit
-
Nov 14, 2026, 09:48Jack Shuang Hou: FDA Approves Bayer’s Sunharbo – First Factor XIa Inhibitor for Secondary Stroke Prevention